Functionally, the addition of an anti-PD-L1 antibody enhanced the phagocytic capacity of CAR-M against tumor cells in vitro (Fig. S11C, D), suggesting that PD-L1 blockade may potentiate immune activation by both alleviating T cell exhaustion and directly enhancing macrophage function. The gene discussed is CD274; the disease is neoplasm.